Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells.

The Abeta peptide of Alzheimer disease is derived from the proteolytic processing of the amyloid precursor proteins (APP), which are considered type I transmembrane glycoproteins. Recently, however, soluble forms of full-length APP were also detected in several systems including chromaffin granules. In this report we used antisera specific for the cytoplasmic sequence of APP to show that primary bovine chromaffin cells secrete a soluble APP, termed solAPPcyt, of an apparent molecular mass of 130 kDa. This APP was oversecreted from Chinese hamster ovary cells transfected with a full-length APP cDNA indicating that solAPPcyt contained both the transmembrane and Abeta sequence. Deglycosylation of solAPPcyt showed that it contained both N- and O-linked sugars, suggesting that this APP was transported through the endoplasmic reticulum-Golgi pathway. Secretion of solAPPcyt from primary chromatin cells was temperature-, time-, and energy-dependent and was stimulated by cell depolarization in a Ca2+-dependent manner. Cholinergic receptor agonists, including acetylcholine, nicotine, or carbachol, stimulated the rapid secretion of solAPPcyt, a process that was inhibited by cholinergic antagonists. Stimulation of solAPPcyt secretion was paralleled by a stimulation of secretion in catecholamines and chromogranin A, indicating that secretion of solAPPcyt was mediated by chromaffin granule vesicles. Taken together, our results show that release of the potentially amyloidogenic solAPPcyt is an active cellular process mediated by both the constitutive and regulated pathways. solAPPcyt was also detected in human cerebrospinal fluid. Combined with the neuronal physiology of chromaffin cells, our data suggest that cholinergic agonists may stimulate the release of this APP in neuronal synapses where it may exert its biological functions. Moreover, vesicular or secreted solAPPcyt may serve as a soluble precursor of Abeta.

[1]  M. Mattson,et al.  Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.

[2]  D. Selkoe,et al.  The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway , 1995, Nature Medicine.

[3]  N. Robakis,et al.  Full‐Length and Truncated Alzheimer Amyloid Precursors in Chromaffin Granules: Solubilization of Membrane Amyloid Precursor Is Mediated by an Enzymatic Mechanism , 1995, Journal of neurochemistry.

[4]  E. Ikonen,et al.  Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites , 1995, Journal of neuroscience research.

[5]  D. Selkoe,et al.  beta-Amyloid, protein processing and Alzheimer's disease. , 1995, Arzneimittel-Forschung.

[6]  N. Robakis,et al.  Involvement of amyloid as a central step in the development of Alzheimer's disease , 1994, Neurobiology of Aging.

[7]  N. Robakis,et al.  Solubilization of full‐length amyloid precursor proteins from PC12 cell membranes , 1994, Journal of neuroscience research.

[8]  T. Saitoh,et al.  Is amyloid causally involved in pathophysiology of alzheimer's disease? , 1994, Neurobiology of Aging.

[9]  L. Refolo,et al.  Study of the phorbol ester effect on Alzheimer amyloid precursor processing: Sequence requirements and involvement of a Cholera toxin sensitive protein , 1994, Journal of neuroscience research.

[10]  N. Katunuma,et al.  Chromaffin cells express Alzheimer amyloid precursor protein in the same manner as brain cells , 1994, Neuroscience Letters.

[11]  R. Tanzi,et al.  Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). , 1994, The Journal of biological chemistry.

[12]  L. Skovgaard,et al.  Intact transmembrane isoforms of the neural cell adhesion molecule are released from the plasma membrane. , 1993, The Biochemical journal.

[13]  R. Vigneri,et al.  An intact and functional soluble form of the insulin receptor is secreted by cultured cells. , 1993, Endocrinology.

[14]  H. Langen,et al.  Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. , 1993, The Journal of biological chemistry.

[15]  G. Perry,et al.  Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  P. Matsudaira,et al.  Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[18]  L. Thal,et al.  Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.

[19]  N. Robakis,et al.  An Alternative Secretase Cleavage Produces Soluble Alzheimer Amyloid Precursor Protein Containing a Potentially Amyloidogenic Sequence , 1992, Journal of neurochemistry.

[20]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[21]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[22]  J. Shioi,et al.  Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells , 1992, Journal of neuroscience research.

[23]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[24]  E. Bock,et al.  Characterization of Soluble Neural Cell Adhesion Molecule in Rat Brain, CSF, and Plasma , 1992, Journal of neurochemistry.

[25]  B. Regland,et al.  The role of amyloid β-protein in Alzheimer's disease , 1992, The Lancet.

[26]  C. Overly,et al.  The beta-amyloid precursor protein is not processed by the regulated secretory pathway. , 1991, Biochemical and biophysical research communications.

[27]  R. Burgoyne.  Control of exocytosis in adrenal chromaffin cells. , 1991, Biochimica et biophysica acta.

[28]  R. Rosenberg,et al.  Increased release of an amyloidogenic C‐terminal Alzheimer amyloid precursor protein fragment from stressed PC‐12 cells , 1991, Journal of neuroscience research.

[29]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[30]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  V. Haroutunian,et al.  Differential brain expression of the Alzheimer's amyloid precursor protein. , 1989, The EMBO journal.

[32]  N. Robakis,et al.  Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. , 1989, Biochemical and biophysical research communications.

[33]  T. Oltersdorf,et al.  Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts , 1989, Cell.

[34]  B. Mroczkowski,et al.  Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity , 1989, Molecular and cellular biology.

[35]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[36]  G. Cole,et al.  Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Selkoe,et al.  Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Multhaup,et al.  Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. , 1988, The EMBO journal.

[39]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[40]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[41]  L. Eiden,et al.  (Met)enkephalin and carboxypeptidase processing enzyme are co-released from chromaffin cells by cholinergic stimulation. , 1985, Biochemical and biophysical research communications.

[42]  Ivan Morozov,et al.  A processing pathway for amyloid β-protein precursor generates a secreted form with an intact carboxyl terminus , 1994 .

[43]  C. Abraham,et al.  Identification of full length β-amyloid precursor protein in human neuronal and non-neuronal cell culture supernatant: a possible extracellular source for the generation of Aβ , 1994 .

[44]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors , 1988 .

[45]  U. V. von Euler,et al.  A fluorimetric micromethod for differential estimation of adrenaline and noradrenaline. , 1955, Acta physiologica Scandinavica. Supplementum.